Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines

Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age

NCT00578175 ·Status: COMPLETED ·Phase: PHASE2

Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM

NCT00969436 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

NCT02184572 ·Status: COMPLETED ·Phase: PHASE3

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age

NCT06855160 ·Status: RECRUITING ·Phase: PHASE3

Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age

NCT01702428 ·Status: COMPLETED ·Phase: PHASE3

MMR and MMRV Vaccines: Effect of Age at First Dose on Safety and Immunogenicity of the Measles Component.

NCT02712203 ·Status: UNKNOWN

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

NCT00861744 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers

NCT04535037 ·Status: COMPLETED ·Phase: PHASE4

Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197

NCT00263653 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.

NCT00432380 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live

NCT05161845 ·Status: COMPLETED ·Phase: PHASE4

Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014

NCT00614614 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children

NCT00228917 ·Status: COMPLETED ·Phase: PHASE3

Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months

NCT06399003 ·Status: COMPLETED ·Phase: PHASE3

Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.

NCT00326118 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine

NCT02880865 ·Status: COMPLETED ·Phase: PHASE4

Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.

NCT00313911 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants

NCT01763268 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

MMR and Varicella Vaccine in Premature Infants

NCT00156559 ·Status: COMPLETED

Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children

NCT01245049 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy Infants

NCT02907216 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers

NCT01106092 ·Status: COMPLETED ·Phase: PHASE2

Safety Study of Live Attenuated Mumps Vaccines in Junior High School Students Under 14 Years Old

NCT05145166 ·Status: COMPLETED

Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children

NCT00197015 ·Status: COMPLETED ·Phase: PHASE3

Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines

NCT00138255 ·Status: TERMINATED